NetworkNewsBreaks – Cybin Inc. (NYSE American: C
Post# of 341
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will report financial results for its third quarter ended Dec. 31, 2021, on Thursday, Feb. 10, 2022. According to the announcement, a conference call will be held on the same day at 8:30 a.m. ET to discuss the results and recent business updates. Cybin’s Chief Executive Officer Doug Drysdale will host the call and, following prepared remarks, Drysdale and other members of the management team will be available to answer questions from participants. Interested parties should visit https://nnw.fm/uBnfq to register for the webcast and join the call by dialing 1-844-200-6205 (U.S. toll free) or 1-833-950-0062 (Canada toll free) and entering code 868712. An archived webcast will be available on the company’s Investor Relations site under the Events & Presentations page.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer